End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.86 CNY | +1.58% | +4.61% | -8.96% |
Mar. 29 | Tianjin Chase Sun Pharmaceutical Co.,Ltd Proposes Final Dividend for 2023 | CI |
Mar. 01 | Tianjin Chase Sun Pharmaceutical's 2023 Profit Slides 15% on Weak Revenue | MT |
Sales 2024 * | 7.45B 1.03B | Sales 2025 * | 8.51B 1.18B | Capitalization | 11.6B 1.6B |
---|---|---|---|---|---|
Net income 2024 * | 706M 97.51M | Net income 2025 * | 853M 118M | EV / Sales 2024 * | 1.56 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.36 x |
P/E ratio 2024 * |
16.1
x | P/E ratio 2025 * |
13.8
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 27.5% |
1 day | +1.58% | ||
1 week | +4.61% | ||
1 month | -2.28% | ||
3 months | +14.88% | ||
6 months | -13.65% | ||
Current year | -8.96% |
Managers | Title | Age | Since |
---|---|---|---|
Dan Zheng
CEO | Chief Executive Officer | 60 | - |
Wu Jun Lan
DFI | Director of Finance/CFO | 49 | - |
Wu Sun
BRD | Director/Board Member | 55 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Xiao Qing Yao
FOU | Founder | 59 | 96-09-22 |
Li Li
BRD | Director/Board Member | 63 | 20-11-17 |
Dan Zheng
CEO | Chief Executive Officer | 60 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 3.86 | +1.58% | 42,203,300 |
24-04-29 | 3.8 | +2.98% | 39,927,060 |
24-04-26 | 3.69 | -1.07% | 39,553,860 |
End-of-day quote Shenzhen S.E., April 29, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.96% | 1.6B | |
+39.33% | 6.11B | |
-18.38% | 4.35B | |
-9.17% | 3.19B | |
+3.98% | 3.15B | |
-3.41% | 2.51B | |
+48.74% | 1.98B | |
-4.82% | 1.74B | |
-1.24% | 1.63B | |
+39.87% | 1.45B |
- Stock Market
- Equities
- 300026 Stock